Biocartis
Biocartis is a leading molecular diagnostics company specializing in innovative, automated solutions for oncology and infectious disease testing. The company’s proprietary Idylla™ platform enables rapid, accurate, and easy-to-use molecular analysis, supporting healthcare professionals in delivering timely and personalized patient care. Biocartis focuses on expanding its comprehensive menu of high-quality diagnostic assays, designed to improve clinical decision-making and streamline laboratory workflows. With a commitment to advancing precision medicine, Biocartis collaborates with global partners to enhance access to cutting-edge diagnostic technologies. The company’s solutions are trusted by hospitals, laboratories, and research institutions worldwide, reinforcing its reputation as a reliable partner in the evolving field of molecular diagnostics.
